- Open
- 10.50
- High
- 11.00
- Low
- 10.00
- Close
- 10.53
- Change
- -0.50 (-4.76%)
- Volume
- 35,767
| 29 Jul 2026 | 07:00:03 | Trading update |
| 29 May 2026 | 07:00:05 | Presentation at Mello2026 |
| 27 May 2026 | 07:00:01 | US tax credit agreement |
| 19 May 2026 | 07:00:08 | Earn-out Consideration and Issue of Equity |
| 28 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 6 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 27 Oct 2023 | Annual Report and Accounts (to 2023-06-30) |
Abingdon Health plc develops, manufactures, and distributes diagnostic devices, focusing on rapid tests and lateral flow tests. The company also provides regulatory consultancy services to businesses in the diagnostics sector. Its customer base includes healthcare providers and organizations in various markets, and it operates primarily in the diagnostics industry. Abingdon Health is involved in research and development to enhance its product offerings and sustainability initiatives.
| 29 Jul 2026 | 07:00:03 | Trading update |
| 29 May 2026 | 07:00:05 | Presentation at Mello2026 |
| 27 May 2026 | 07:00:01 | US tax credit agreement |
| 19 May 2026 | 07:00:08 | Earn-out Consideration and Issue of Equity |
| 28 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 6 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 27 Oct 2023 | Annual Report and Accounts (to 2023-06-30) |
Abingdon Health plc develops, manufactures, and distributes diagnostic devices, focusing on rapid tests and lateral flow tests. The company also provides regulatory consultancy services to businesses in the diagnostics sector. Its customer base includes healthcare providers and organizations in various markets, and it operates primarily in the diagnostics industry. Abingdon Health is involved in research and development to enhance its product offerings and sustainability initiatives.
| 11 May 2026 |
| 07:00:10 |
| Launch of LVOne Stroke Test by UpFront Diagnostics |
| 20 Apr 2026 |
| AIM Market Roundup: Clean Power Hydrogen, Abingdon Health, AMS |
| 2 Apr 2026 | Abingdon Health chair on H1 performance, new contracts, OTC admission, and the path ahead |
| 30 Mar 2026 | AIM movers: Abingdon Health wins US contracts and Mirriad Advertising running out of cash |
| 30 Mar 2026 | Abingdon Health up 14% after it wins £4.8m of US contracts for multiplex diagnostic test development |
| 12 Mar 2026 | AIM movers: Restore upgrade and ex-dividends |
| 10 Nov 2025 | AIM movers: Eagle Eye US contract and Buccaneer Energy well not commercial |
| 11 May 2026 |
| 07:00:10 |
| Launch of LVOne Stroke Test by UpFront Diagnostics |
| 20 Apr 2026 |
| AIM Market Roundup: Clean Power Hydrogen, Abingdon Health, AMS |
| 2 Apr 2026 | Abingdon Health chair on H1 performance, new contracts, OTC admission, and the path ahead |
| 30 Mar 2026 | AIM movers: Abingdon Health wins US contracts and Mirriad Advertising running out of cash |
| 30 Mar 2026 | Abingdon Health up 14% after it wins £4.8m of US contracts for multiplex diagnostic test development |
| 12 Mar 2026 | AIM movers: Restore upgrade and ex-dividends |
| 10 Nov 2025 | AIM movers: Eagle Eye US contract and Buccaneer Energy well not commercial |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £939m | +0.1% | |
| £48m | -0.3% | |
| £29m | +0.0% | |
ABDXAbingdon Health PLC | £27m | +0.6% |
| £14m | -0.5% | |
| £11m | +0.0% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £939m | +0.1% | |
| £48m | -0.3% | |
| £29m | +0.0% | |
ABDXAbingdon Health PLC | £27m | +0.6% |
| £14m | -0.5% | |
| £11m | +0.0% |
